Australia. Prestigious Scholar Award from Sydney Adventist Hospital

    35
    0
     Australia.  Prestigious Scholar Award from Sydney Adventist Hospital

    Adventist News Dr. Ann Lippert, a researcher at Sydney Adventist Hospital, won the Rosalind Franklin Society of Science Award for her article demonstrating the effectiveness of light therapy in reducing clinical signs of Parkinson’s disease (PD). The study, which won a prestigious award, titled “Telephototherapy for Clinical Signs of Parkinson’s Disease: A Case Series During Covid-19,” was published in the journal. Photomodulation, photomedicine and laser surgery in 2021. It is the first document of its kind to demonstrate the mechanism of remote photomodulation (Pbm) to help symptoms of MP.

    MP is a progressive neurodegenerative disease that has no cure and few treatment options. There is a strong association between the microbiome-gut-brain axis and MB.

    Pbm in animal models can reduce signs of Parkinson’s disease and protect neurons when applied directly to the head or parts of the body.

    Dr. Lippert’s study, conducted in the Photomodulation Therapy Clinic at Sydney Adventist Hospital, involved seven participants who were treated with PBM in the abdomen and neck three times a week for twelve weeks. At the time of enrollment, participants were assessed for mobility, balance, cognitive ability, fine motor skills, and sense of smell after twelve weeks of in-clinic treatment and thirty-three weeks of home treatment.

    A number of clinical signs of Parkinson’s disease have been shown to improve after telephototherapy, including mobility, cognition, dynamic equilibrium, spiral drag test, and sense of smell.

    “Our study shows that PBM has been shown to be a potentially safe and effective treatment for a range of clinical signs and symptoms of PM,” said Dr. Lippert. No other treatment has achieved this.”

    Several studies have observed that the gut microbiome of Parkinson’s patients is drastically altered, with certain proteins traveling from the gut to the brain. Intestinal dysbacteriosis refers to an inflammatory disease. Highlighting the stomach stimulates the body to produce anti-inflammatory chemicals. Once the inflammation subsides, the body goes into homeostasis and can produce positive clinical effects.

    The doctor said she was honored to win this award and thanked Sydney Adventist Hospital, “in particular Professor. Jeffrey Herks, my mentor, research associate and head of research at the hospital, for supporting my work and enabling this clinical innovation to change the treatment of so many people around the world.”

    Click here to consult Full article by Dr. Lippert.

    [Fonte: Adventist Record]


    Adventist News

    Previous articleGasoline, the illegal savings trick: You’re practically walking for free
    Next articleChildren will go blind, a Canadian couple will take them around the world to fill their “visual memories” – Corriere.it
    "Devoted bacon guru. Award-winning explorer. Internet junkie. Web lover."

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here